PADAMOLOGY LIBRARY

Published Research

Practical insights on medical monitoring, patient safety, trial execution, and the decisions that shape early oncology development.

Simran Padam 7/1/21 Simran Padam 7/1/21

Phase I/II Trial of Palbociclib, Pembrolizumab, and Letrozole in Patients with Hormone Receptor-Positive Metastatic Breast Cancer

A Phase I/II study evaluating palbociclib, pembrolizumab, and letrozole in hormone receptor-positive metastatic breast cancer.

Simran Padam 3/21/21 Simran Padam 3/21/21

A Phase II study of neratinib in older adults with HER2-amplified or HER2/3-mutated metastatic breast cancer.

Simran Padam 2/1/21 Simran Padam 2/1/21

A Phase II trial evaluating pembrolizumab and enobosarm in androgen receptor-positive metastatic triple-negative breast cancer.

Simran Padam 5/25/20 Simran Padam 5/25/20

A published abstract examining the tolerability of neratinib in older adults with HER2-positive or HER2-mutated metastatic breast cancer.

Simran Padam 2/15/20 Simran Padam 2/15/20

Research exploring gut microbiome profiles among patients with metastatic breast cancer receiving immune checkpoint inhibitor therapy.

Simran Padam 2/1/20 Simran Padam 2/1/20

A Phase II study investigating pembrolizumab, letrozole, and palbociclib in patients with metastatic estrogen receptor-positive breast cancer.